Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
47.9M
-
Shares change
-
+2.2M
-
Total reported value, excl. options
-
$1.03B
-
Value change
-
+$40.3M
-
Number of buys
-
32
-
Number of sells
-
-14
-
Price
-
$21.33
Significant Holders of Edgewise Therapeutics, Inc. - Common Stock (EWTX) as of Q2 2021
54 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock as of Q2 2021.
Edgewise Therapeutics, Inc. - Common Stock (EWTX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.9M shares
of 106M outstanding shares and own 45.24% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (13.9M shares), Novo Holdings A/S (5.59M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.93M shares), Cormorant Asset Management, LP (3.14M shares), VIKING GLOBAL INVESTORS LP (2.73M shares), RA CAPITAL MANAGEMENT, L.P. (2.61M shares), CITADEL ADVISORS LLC (2.46M shares), FMR LLC (2.42M shares), JANUS HENDERSON GROUP PLC (1.79M shares), and New Leaf Venture Partners, L.L.C. (1.55M shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.